A500ETF基金(512050)近20日“吸金”27亿元，港股创新药ETF本周领涨

Market Performance - The Shanghai Composite Index fell by 0.97%, closing below 4000 points, while the ChiNext Index dropped by 2.82% [1] - The Hang Seng Index and the Hang Seng Tech Index experienced significant declines, with the latter falling by 2.83% and reaching a low of 3.1% during trading [1] - For the week, the Hang Seng China Enterprises Index and the Hang Seng Index rose by 1.4% and 1.26%, respectively, while the Shanghai Composite Index saw a slight decline of 0.18% [1][2] ETF Performance - The "Global Vision, Betting on China" top ten core ETFs saw a minor pullback of 0.325% this week but recorded a year-to-date increase of 32.62%, outperforming the CSI 300 Index by 15 percentage points [3] - The Hong Kong Innovative Drug ETF was the best performer this week, rising by 5.9% and achieving a year-to-date increase of 93% [7] - The A500 ETF (512050) experienced a slight decline of 1.02% this week but had a net inflow of 2.36 billion yuan over the first four days of the week, totaling 27.07 billion yuan over the past 20 days [3][6] Innovative Drug Sector - The innovative drug sector is showing strong fundamentals, with companies like BeiGene reporting a 41.1% year-on-year revenue increase in Q3, reaching 10.077 billion yuan [9] - The sector is benefiting from a surge in overseas licensing deals, with total transaction amounts exceeding 100 billion USD by October 2025, indicating a significant revaluation of domestic innovative drugs [9] - Policy support, performance realization, and accelerated internationalization are driving improvements in the innovative drug sector's fundamentals, enhancing its medium to long-term investment value [9] U.S. Market Dynamics - The U.S. stock market is facing liquidity challenges due to a prolonged government shutdown and increased debt issuance, which has led to a significant cash drain from the market [12][13] - Hedge funds and institutions have been net sellers of U.S. stocks and ETFs, with over 67 billion USD sold this year, exacerbating liquidity pressures [13] - The Federal Reserve's mixed signals on interest rates have created volatility, particularly affecting technology stocks, as the market adjusts to changing rate expectations [12][14]